Evaluating cost efficiency of SNP chips in genome-wide association studies
✍ Scribed by Chun Li; Mingyao Li; Ji-Rong Long; Qiuyin Cai; Wei Zheng
- Publisher
- John Wiley and Sons
- Year
- 2008
- Tongue
- English
- Weight
- 201 KB
- Volume
- 32
- Category
- Article
- ISSN
- 0741-0395
No coin nor oath required. For personal study only.
✦ Synopsis
Abstract
Genome‐wide association (GWA) studies have recently emerged as a major approach to gene discovery for many complex diseases. Since GWA scans are expensive, cost efficiency is an important factor to consider in study design. However, it often requires extensive and time‐consuming computer simulations to compare cost efficiency across different single nucleotide polymorphism (SNP) chips. Here, we propose two simulation‐free approaches to cost efficiency comparisons across SNP chips. In the first method, the overall power under a given disease model is calculated for each SNP chip and various sample sizes. Then SNP chips can be compared with respect to the sample sizes required to achieve the same level of power. In the second method, for a desired level of genomic coverage, the effective r^2^ threshold values are calculated for each SNP chip. Since r^2^ is inversely proportional to the sample size to achieve the same power, the required sample sizes can then be compared among SNP chips. These two methods are complementary to each other. The first approach provides direct power comparisons, but it requires information on disease model and may not be reliable for SNP chips that contain many non‐HapMap SNPs. The second approach allows sample size comparisons based on the coverage of SNP chips, and it can be modified for SNP chips that contain non‐HapMap SNPs. These methods are particularly relevant for large epidemiological studies in which enough subjects are available for GWA screening and follow‐up stages. We illustrate these approaches using five currently available whole genome SNP chips. Genet. Epidemiol. 2008. © 2008 Wiley‐Liss, Inc.
📜 SIMILAR VOLUMES
In this article, we develop a powerful test for identifying single nucleotide polymorphism (SNP)-sets that are predictive of survival with data from genome-wide association studies. We first group typed SNPs into SNP-sets based on genomic features and then apply a score test to assess the overall ef
## Abstract Population‐based case‐control design has become one of the most popular approaches for conducting genome‐wide association scans for rare diseases like cancer. In this article, we propose a novel method for improving the power of the widely used single‐single‐nucleotide polymorphism (SNP
## Abstract To identify genetic variants with modest effects on complex human diseases, a growing number of networks or consortia are created for sharing data from multiple genome‐wide association studies on the same disease or related disorders. A central question in this enterprise is whether to